FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES; SUBMISSION FOR OFFICE OF MANAGEMENT AND BUDGET REVIEW; COMMENT REQUEST; CURRENT GOOD MANUFACTURING PRACTICE (CGMP): MANUFACTURING, PROCESSING, PACKING, AND HOLDING OF DRUGS; GMP FOR FINISHED PHARMACEUTICALS (INCLUDING ACTIVE PHARMACEUTICAL INGREDIENTS) AND THE ADVANCED MANUFACTURING TECHNOLOGIES DESIGNATION PROGRAM

WASHINGTON, May 21 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program.

The notice was published in the Federal Register on May 21 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Bud...